Pramiracetam
Cognitive · Racetam
Tier C+
Bottom line
Read Off Label grades Pramiracetam as C+ (5.7/10) based on weak evidence, variable benefit magnitude, and a low-risk safety profile.
Most potent racetam by dose.
Studied, labeled, or reported-use context: 400-1200 mg/day PO divided, with fat — Research chem in US; not individualized guidance.
What the evidence says
Most potent racetam by dose. 1990s trials in TBI and AD showed modest signals but never pursued to approval. Users commonly report 'memory formation' effects. Very limited modern data. Choline co-administration is nootropic lore without clinical validation.
Mechanism
High-affinity choline uptake enhancer (HACU); increases hippocampal ACh synthesis; no direct receptor binding; fat-soluble
Studied, labeled, or reported dose & route
400-1200 mg/day PO divided, with fat
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Pramiracetam's effects?
- Read Off Label rates the evidence for Pramiracetam as Weak and the benefit magnitude as variable, producing an overall grade of C+ (5.7/10). Most potent racetam by dose.
- What safety findings are reported for Pramiracetam?
- Pramiracetam has a low risk profile in the database. Low (reported) Legal status: Research chem in US.
- What doses or routes are reported for Pramiracetam?
- 400-1200 mg/day PO divided, with fat This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Pramiracetam work?
- High-affinity choline uptake enhancer (HACU); increases hippocampal ACh synthesis; no direct receptor binding; fat-soluble
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.